FDA Adverse Event Malfunction Summary report: N

REAGENT RED BLOOD CELLS BIOTESTCELL 3

MDR report key: 2149050 · Received June 17, 2011

Report

Report Number
9610824-2011-00082
Event Type
Malfunction
Date Received
June 17, 2011
Date of Event
May 23, 2011
Report Date
June 17, 2011
Manufacturer
BIO-RAD MEDICAL DIAGNOSTICS GMBH
Product Code
LKJ
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

THE CUSTOMER COMPLAINED FALSE (B)(6) REACTIONS OF PT SAMPLES WITH CELL 2 OF BIOTESTCELL 3 IN THE GEL CARD. WE RECEIVED THREE AFFECTED SAMPLES BUT NOT THE COMPLAINED LOT OF BIOTESTCELL 3. THE SAMPLES PLUS THE RETENTION SAMPLE OF BIOTESTCELL 3 WERE TESTED WITH A GEL CARD IN OUR QC LAB. THE THREE SAMPLES SHOWED (B)(6) REACTIONS WITH CELL 2 OF BIOTESTCELL 3. FURTHERMORE THE SAMPLES WERE TESTED IN THE 3-PHASE-TUBE TEST AND REACTED (B)(6). THE THREE SAMPLES SHOWED ONLY (B)(6) REACTIONS IN A TUBE METHOD WITH PROLONGED INCUBATION TIME AT 4 DEGREES CELSIUS. BUT THIS METHOD IS NOT CONFORM TO THE DESCRIBED METHODS OF INSTRUCTION FOR USE. THE CORRECT FUNCTION OF THE AFFECTED LOT BIOTESTCELL 3 WAS CONFIRMED BY TESTING DIFFERENT (B)(6) SAMPLES. ALL (B)(6) REACTIONS WERE CORRECT. THE CUSTOMER SAMPLES REACTED (B)(6) WITH CELL 2 OF BIOTESTCELL 3 IN THE GEL CARD. THE INTENDED USE OF THE PRODUCT IS THE DETECTION OF UNEXPECTED ANTIBODIES IN THE TUBE TEST AND SOLID PHASE TEST SOLIDSCREEN II WITH TANGO OPTIMO AND NOT THE GEL SYSTEM.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 REAGENT RED BLOOD CELLS BIOTESTCELL 3 BIOTESTCELL 3 LKJ BIO-RAD MEDICAL DIAGNOSTICS GMBH 8115011

Patients

Seq Age Sex Outcome Treatment
1 ORTHO PANEL C: LOT RC380